{"id":52743,"name":"FULCRUM THERAPEUTICS, INC.","slug":"fulcrum-therapeutics-inc","state":"MA","country":"United States of America","description":"identify high-value, de-risked targets at speed and scale for rare genetic diseases","totalSpending":320000,"filings":11,"yearlySpending":[{"year":2022,"income":50000},{"year":2023,"income":120000},{"year":2024,"income":150000}],"issues":["HCR","PHA"],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["KATHERINE LANDES","ALEXANDER ROOT","JACOB JACKSON","PATROSKI LAWSON","PAULA GUTIERREZ"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","White House Office"],"sampleDescriptions":["Any legislation regarding rare disease treatment","H. RES. 1330 H.R. 6216/S. 3389, the Sickle Cell Disease Comprehensive Care Act H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 S. 1644/H.R. 3761, the Promising Pathway Act S. ","H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction","Senate HELP Minority- FDA Modernization","FDA Matters"],"years":[2022,2023,2024]}